Bartłomiej Gmaj

Dr. Bartłomiej Gmaj

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2014 in Community Mental Health Journal
Verified
Journal Article
Open access
PDF file
MKMaciej Kopera
Maciej Kopera
HSHubert Suszek
Hubert Suszek
EBErin Bonar
Erin Bonar
MMMaciej Myszka
Maciej Myszka
BGBartłomiej Gmaj
Bartłomiej Gmaj
MWMarcin Wojnar
Marcin Wojnar
The study investigated explicit and implicit attitudes towards people with mental illness among medical students (non-professionals) with no previous contact with mentally ill patients and psychiatrists and psychotherapists (professionals) who had at least 2 years of professional contact with mentally ill patients. Explicit attitudes where assessed by self-report. Implicit attitudes were measured with the Go/No-Go Association Task, a variant of the Implicit Association Test that does not require the use of a comparison category. Compared to non-professionals, mental health professionals reported significantly higher approach emotions than non-professionals towards people with mental illness, showed a lesser tendency to discriminate against them, and held less restrictive attitudes. Both groups reported negative implicit attitudes towards mentally ill. Results suggest that both non-professionals and professionals display ambivalent attitudes towards people with mental illness and that professional, long-term contact with people with mental illness does not necessarily modify negative implicit attitudes.

15 October 2017 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
PDF file
DWDorota Wołyńczyk-Gmaj
Dorota Wołyńczyk-Gmaj
ARAnna Różańska-Walędziak
Anna Różańska-Walędziak
SZSimon Ziemka
Simon Ziemka
MUMarcin Ufnal
Marcin Ufnal
ABAneta Brzezicka
Aneta Brzezicka
MWMarcin Wojnar
Marcin Wojnar
Deterioration in sleep quality seems to be a natural consequence of physical changes during pregnancy. It is still unclear if insomnia in pregnancy is associated with the same factors as chronic insomnia in the general population. The aim of this study was to explore the determinants of insomnia during pregnancy. The study included 266 women (mean age: 30.6 ± 5 years, weeks of pregnancy: 36 [interquartile range 32-38]) recruited at the Department of Gynecology and Obstetrics, Medical University of Warsaw. The assessment of variables was performed using the Athens Insomnia Scale (AIS), Beck Depression Inventory (BDI), Regestein Hyperarousal Scale (HS), Epworth Sleepiness Scale (ESS), General Practice Physical Activity Questionnaire, and a semi-structured interview about different sleep disorders. Almost 40% of the women in our study received a diagnosis of insomnia based on AIS cutoff scores. The between-group analyses indicated that HS score, BDI score, eating at night, legs tingling, nightmares, snoring, and myoclonus differentiated the groups of individuals with insomnia from those without insomnia. Other variables were not significantly different between the groups. We divided individuals with insomnia in terms of insomnia duration: 49% developed insomnia at least 1 year before the study onset and 39.6% during pregnancy. For further analyses we used only the women in whom insomnia developed during pregnancy. Logistic regression confirmed that depressive symptoms (BDI) and eating at night were significant predictors of insomnia in pregnancy. Depressive symptoms and night eating are key factors related to insomnia developed during pregnancy.

DWDorota Wołyńczyk-Gmaj
Dorota Wołyńczyk-Gmaj
AJAndrzej Jakubczyk
Andrzej Jakubczyk
ETElisa M Trucco
Elisa M Trucco
PKPaweł Kobyliński
Paweł Kobyliński
JZJustyna Zaorska
Justyna Zaorska
MKMaciej Kopera
Maciej Kopera
Alcohol craving is associated with insomnia symptoms, and insomnia is often reported as a reason for alcohol relapse. The current study examined associations between emotional regulation, anxiety, and insomnia among a group of 338 patients with alcohol use disorder (AUD). Because insomnia most often develops after stressful experiences, it was expected that anxiety symptoms would mediate the association between emotional dysregulation and insomnia severity. It was also expected that an insomnia diagnosis would moderate the association between emotional dysregulation and anxiety symptoms, namely that higher anxiety levels would be found in individuals with insomnia than in those without insomnia. Insomnia severity was assessed with a total score based on the Athens Insomnia Scale (AIS). Additionally, an eight-point cut-off score on the AIS was used to classify participants as with (n = 107) or without (n = 231) an insomnia diagnosis. Moreover, participants completed the Emotion Regulation Scale (DERS; total score) and the Brief Symptoms Inventory (BSI; anxiety). Individuals with insomnia did not differ from those without insomnia in age (p = 0.86), duration of problematic alcohol use (p < 0.34), mean days of abstinence (p = 0.17), nor years of education (p = 0.41). Yet, individuals with insomnia endorsed higher anxiety (p < 0.001) and higher emotional dysregulation (p < 0.001). Anxiety symptoms fully mediated the association between emotional dysregulation and insomnia severity (p < 0.001). Furthermore, insomnia diagnosis positively moderated the association between emotional dysregulation and anxiety (p < 0.001). Our results suggest that emotional dysregulation can lead to insomnia via anxiety symptoms. Treating anxiety symptoms and emotional dysregulation could help to prevent or alleviate symptoms of insomnia in people with AUD. Moreover, treating insomnia in people with AUD may also have a positive effect on anxiety symptoms.

4 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DWDorota Wołyńczyk-Gmaj
Dorota Wołyńczyk-Gmaj
AZAleksandra Ziółkowska
Aleksandra Ziółkowska
PRPiotr Rogala
Piotr Rogala
DSDawid Scigala
Dawid Scigala
LBLudwik Bryła
Ludwik Bryła
MWMarcin Wojnar
Marcin Wojnar
Few studies have explored the influence of an Animal-Assisted Intervention on patients with mental disorders. We investigated it’s impact on anxiety symptoms. We divided 51 patients with anxiety symptoms into two groups—treatment group, that went for a short 15–20 min’ walk with a dog, his handler and a researcher and control group, that went for a walk only with a researcher. We used State-Trait Anxiety Inventory (STAI), Visual Analogue Scale (VAS) of fear, Beck Depression Inventory (BDI), Ford Insomnia Response to Stress (FIRST), Brief symptom Inventory (BSI) and VAS of satisfaction after trial to assess. We also checked the resting blood pressure and resting heart rate before and after performing psychological tests while sitting. We have obtained full data of 21 people from the research group and 26 people from the control group. After the intervention, the treatment group reported lower anxiety levels as a state (Mean (M) = 34.35; Standard Deviation (SD) = 6.9 vs. M = 40.94; SD = 8.6) and fear (M = 1.05; SD = 1.0 vs. M = 2.04; SD = 2.2) than the control group. After a walk with a dog, trait anxiety (M = 34.35; SD = 6.9 vs. M = 46.3; SD = 9.6), state anxiety (M = 48.9; SD = 7.2 vs. M = 53.9; SD = 7.8), fear (M = 1.05; SD= 1.0 vs. M = 2.57; SD = 2.3) and resting heart rate (M = 71.05; SD = 12.3 vs. M = 73.67; SD = 13.1) decreased significantly, while walking without a dog only reduced state anxiety (M = 47.24; SD = 11.0 vs. M = 40.94; SD = 8.6). Multivariate analysis of variance showed that after the walk, state anxiety was significantly lower in the treatment group than in the control group, F(1.35) = 6.706, p <0.05, η2 = 0.161. Among those who walked with a dog, the intervention also led to significant decreases in fear and resting heart rate, F(1.44) = 11.694, p < 0.01, η2 = 0.210 and F(1.45) = 8.503; p < 0.01; η2 = 0.159, respectively. For anxious patients, a short walk with a dog is more beneficial than a walk without one. We found significant positive effects of a dog’s company on vegetative arousal and mental comfort. This is another study confirming the possible therapeutic effect of the animal on anxiety symptoms. Further research is required, especially in the large groups of patients, as recommendations on the use of Animal Assisted Interventions (AAI) are needed.

1 December 2015 in Alcoholism and Drug Addiction
Verified
Journal Article
Open access
AMAneta Michalska
Aneta Michalska
MKMaciej Kopera
Maciej Kopera
BGBartłomiej Gmaj
Bartłomiej Gmaj
AŁAgata Łoczewska
Agata Łoczewska
Natalia SzejkoNatalia Szejko
Natalia Szejko
MWMarcin Wojnar
Marcin Wojnar
Alcohol dependence is an important risk factor for suicidal behaviours. Current data show that between 14 and 43% of alcohol-dependent patients attempt suicide. The aim of the present study was to analyse the risk factors for suicide attempts among patients treated for alcohol dependence. Medical data of 994 patients hospitalised in Alcohol Detoxification and Rehabilitation Units of Nowowiejski Hospital in Warsaw were analysed. The relationships between variables that are thought to be related to the prevalence of suicide attempts in this population were evaluated. The relevant psycho-social and demographic data as well as information on alcohol use and treatment history were included. 292 (29%) patients confirmed suicide attempts in the past. Among the variables included in the logistic regression model, previous episodes of delirium tremens, earlier onset of alcohol dependence, comorbidity of somatic disorders, and unemployment proved to be significant risk factors for previous suicide attempts. The higher prevalence of suicide attempts among patients with previous episodes of delirium tremens and earlier onset of alcohol dependence confirms the relationship between the severity of alcohol dependence and suicide attempts. The effect of unemployment and comorbidity of somatic disorders on incidence of suicide attempts might presumably be mediated by co-occurring pain, depression, and poorer social functioning. Earlier onset of alcohol dependence and previous episodes of delirium tremens are the risk factors of suicide attempts attributable to the severity of alcohol dependence. The other risk factors (unemployment and somatic disorders) are nonspecific to alcohol dependence, and were previously found to increase the risk in various psychiatric populations. Uzależnienie od alkoholu jest istotnym czynnikiem ryzyka zachowań samobójczych. Uważa się, że próbę samobójczą podejmuje od 14 do 43% osób uzależnionych. Celem przedstawionej pracy była analiza czynników ryzyka prób samobójczych w grupie osób leczonych z powodu uzależnienia od alkoholu. Analizą objęto historie chorób 994 pacjentów hospitalizowanych w Oddziale Detoksykacyjnym oraz Odwykowym Szpitala Nowowiejskiego w Warszawie. Badano zależności między zmiennymi, które mogłyby mieć związek z próbami samobójczymi w badanej populacji. Uwzględniono dane demograficzne, informacje dotyczące historii używania alkoholu oraz przebiegu leczenia. Próby samobójcze w przeszłości potwierdziło 292 pacjentów (29%). Spośród uwzględnionych w modelu regresji logistycznej zmiennych, obecność majaczenia, wcześniejszy wiek początku uzależnienia, współwystępowanie chorób somatycznych oraz brak zatrudnienia okazały się istotnymi czynnikami ryzyka prób samobójczych w wywiadzie. Większa częstość prób samobójczych u pacjentów z wywiadem epizodów majaczenia oraz wcześniejszym wiekiem początku uzależnienia od alkoholu wskazuje na związek między ciężkością przebiegu uzależnienia a występowaniem prób samobójczych. Współwystępujące choroby somatyczne oraz brak zatrudnienia zwiększają częstość prób samobójczych, przypuszczalnie przez towarzyszący ból, istnienie zespołów depresyjnych, pogorszenie funkcjonowania społecznego. Do czynników związanych z podejmowaniem prób samobójczych zależnych od ciężkości przebiegu uzależnienia od alkoholu należą: wcześniejszy wiek początku uzależnienia oraz obecność w wywiadzie majaczenia alkoholowego. Pozostałe to, jak sądzimy, czynniki niespecyficzne, takie jak brak zatrudnienia i współwystępowanie chorób somatycznych.

1 January 2018 in Journal of Epileptology
Verified
Journal Article
Open access
PDF file
BGBartłomiej Gmaj
Bartłomiej Gmaj
JMJerzy Majkowski
Jerzy Majkowski
JSJan Szczypiński
Jan Szczypiński
JJJoanna Jędrzejczak
Joanna Jędrzejczak
BMBeata Majkowska-Zwolińska
Beata Majkowska-Zwolińska
DWDorota Wołyńczyk-Gmaj
Dorota Wołyńczyk-Gmaj
Depressive symptoms are very frequent in the population of patients with epilepsy. Comorbidity between depression and epilepsy is estimated in the range of 9–62%. There are no epidemiological studies in Poland thus far in that area and there is no translated and validated screening tool for depression dedicated for persons with epilepsy (PWEs). In this study we intended to validate the Polish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), which is a short and accurate scale used in many countries for assessment of depressive symptoms in PWEs.